Search

Your search keyword '"Bharti PK"' showing total 146 results

Search Constraints

Start Over You searched for: Author "Bharti PK" Remove constraint Author: "Bharti PK"
146 results on '"Bharti PK"'

Search Results

5. Analysis of diagnostic biomarkers for malaria: Prospects on rapid diagnostic test (RDT) development.

6. A constant contact community-based epidemiological investigation (C3EI) as part of malaria elimination demonstration project, Mandla district, Madhya Pradesh, India.

7. Mutations in Plasmodium falciparum Kelch13 (PfK13) dysregulates PI3K/AKT signalling pathway in artemisinin resistance.

9. Spatiotemporal Epidemiology of Malaria in India from 2007 to 2022.

10. Low Prevalence of Antimalarial Resistance Mutations in India During 2014-2015: Impact of Combining First-line Therapy With Primaquine.

11. Spectroscopic insight into breast cancer: profiling small extracellular vesicles lipids via infrared spectroscopy for diagnostic precision.

12. Malaria elimination: situation analysis of cases in India, the state of Madhya Pradesh in central India, and district Mandla of Madhya Pradesh.

13. Systematic Review and Geospatial Modeling of Molecular Markers of Resistance to Artemisinins and Sulfadoxine-Pyrimethamine in Plasmodium falciparum in India.

14. Malaria Slide Bank to Strengthen and Improve the Quality of Malaria Diagnosis: A National Slide Repository in India.

15. Time to implement tailored interventions in Chhattisgarh, east-central India to reach malaria elimination.

16. Repurposing FDA-approved drugs to target malaria through inhibition of dihydrofolate reductase in the folate biosynthesis pathway: A prospective approach.

17. A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.

18. Time series analysis of malaria cases to assess the impact of various interventions over the last three decades and forecasting malaria in India towards the 2030 elimination goals.

19. Science of malaria elimination: using knowledge of bottlenecks and enablers from the Malaria Elimination Demonstration Project in Central India for eliminating malaria in the Asia Pacific region.

20. A computational strategy for systematic virtual screening of plasmodium falciparum heme detoxification protein inhibitors from the Drugbank database.

21. Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis.

22. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India.

23. Age-specific malaria vulnerability and transmission reservoir among children.

24. Unravelling the Influence of Host Genetic Factors on Malaria Susceptibility in Asian Populations.

25. Screening of potential antiplasmodial agents targeting cysteine protease-Falcipain 2: a computational pipeline.

26. A comparative assessment of the community frontline health workers for their knowledge and practices of malaria diagnosis and treatment in three contiguous districts Mandla, Balaghat, and Dindori of Madhya Pradesh, India.

27. Evaluation of the model malaria elimination strategy in Mandla district along with its neighbouring districts: a time series analysis from 2008 to 2020.

28. Tracking district-level performance in the context of achieving zero indigenous case status by 2027.

29. Linkages between malaria and malnutrition in co-endemic regions of India.

30. Mass screening and treatment (MSaT) for identifying and treating asymptomatic cases of malaria-malaria elimination demonstration project (MEDP), Mandla, Madhya Pradesh.

31. A case report of late treatment failure in Plasmodium falciparum malaria in a traveler from the Democratic Republic of the Congo to India.

32. A qualitative study on community perceptions on quality of healthcare services they received in the Malaria Elimination Demonstration Project in district Mandla, India.

33. Limited genetic diversity and expression profile of Plasmodium falciparum haem detoxification protein: a possible diagnostic target.

34. Identification of Potential Antimalarial Drug Candidates Targeting Falcipain-2 Protein of Malaria Parasite-A Computational Strategy.

35. Significance of nested PCR testing for the detection of low-density malaria infection amongst febrile patients from the Malaria Elimination Demonstration Project in Mandla, Madhya Pradesh, India.

36. India may need an additional metric to assess the endemicity of malaria in low surveillance districts.

37. Process development and preclinical evaluation of a major Plasmodium falciparum blood stage vaccine candidate, Cysteine-Rich Protective Antigen (CyRPA).

38. Mining and analysis of microsatellites in human coronavirus genomes using the in-house built Java pipeline.

39. Plasmodium malariae Detected by Microscopy in the International Bordering Area of Mizoram, a Northeastern State of India.

41. Unreported mixed Plasmodium species infection may increase vivax malaria in India: a challenge for malaria elimination.

42. Effect of milking environment enrichment through music on production performance and behaviour in cattle.

43. microRNAs: An opportunity to overcome significant challenges in malaria detection and control.

44. Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of Mycoplasma pneumoniae in pediatric community-acquired lower respiratory tract infections.

45. Analysis of the insecticide resistance mechanism in Anopheles culicifacies sensu lato from a malaria-endemic state in India.

46. Genetic diversity of Plasmodium falciparum AMA-1 antigen from the Northeast Indian state of Tripura and comparison with global sequences: implications for vaccine development.

47. Polymerase Chain Reaction-Based Malaria Diagnosis Can Be Increasingly Adopted during Current Phase of Malaria Elimination in India.

48. Microclimate modification in Murrah buffalo (Bubalus bubalis) heifers during summer: Effect on intake, growth and hematobiochemistry.

49. Peer review analyze: A novel benchmark resource for computational analysis of peer reviews.

50. Plasmodium falciparum Cysteine-Rich Protective Antigen (CyRPA) Elicits Detectable Levels of Invasion-Inhibitory Antibodies during Natural Infection in Humans.

Catalog

Books, media, physical & digital resources